Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tiba Al Sagheer"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Chimeric Antigen Receptor T-cell (CAR-T) therapy has transformed the treatment landscape for hematological malignancies, showing high efficacy in patients with relapsed or refractory (R/R) disease and otherwise poor prognosis in the pre-CAR-T era. Th
Externí odkaz:
https://doaj.org/article/ae35ea33e88f4699b7be5f45c92e4777
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 9, Iss , Pp 100223- (2023)
Given the scarcity of data available on Plasmablastic lymphoma (PBL) and human immunodeficiency virus (HIV) patients undergoing allogeneic hematopoietic stem cell transplant (Allo-HSCT), we share our experience. We review the barriers overcome by the
Externí odkaz:
https://doaj.org/article/b9c4f100ba484efdb8420c374e21cc66
Publikováno v:
American Journal of Health-System Pharmacy. 80:36-43
Purpose To review the pharmacology, efficacy, safety, dosing and administration, and place in therapy of asciminib, an oral tyrosine kinase inhibitor (TKI) used as a third-line treatment option for Philadelphia chromosome–positive chronic myeloid l
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Transplantation and Cellular Therapy. 28:S383
Autor:
Tiba Al Sagheer, Cher Y. Enderby
Publikováno v:
Clinical Transplantation. 33
Tacrolimus is utilized as maintenance immunosuppression in solid organ transplant (SOT). Current literature has reported conflicting conversion ratios when transitioning between oral and sublingual tacrolimus, and the exact conversion ratio has not b